NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Parsons Posts Loss, Slashes 2026 Outlook as It Reshapes Portfolio

Parsons shares crashed after a $15.2M Q2 loss and sharp cuts to 2026 revenue and EBITDA guidance from portfolio reshaping.

Parsons Posts Loss, Slashes 2026 Outlook as It Reshapes Portfolio
Credit: Parsons Corporation
Already have an account? Sign in.
07/29/2026 · 11:59 AM
PSN
/ Don’t stop at just one post.

Related↓

Parsons Stock Drops After Losing Air-Traffic Control Contract
Featured/ 12/05/2025 · 8:56 AM

Parsons Stock Drops After Losing Air-Traffic Control Contract

Parsons (PSN) shares fell after losing the $12.5B air-traffic control modernization contract to Peraton, disappointing investors who expected the company to win.

/ Subscriber only
/ Read more

Feed↓

Xos Wins First U.S. Air Force Contract, Enters Defense Market
08/17/2026 · 5:18 PM

Xos Wins First U.S. Air Force Contract, Enters Defense Market

Xos secures its first U.S. Air Force contract to build a military-grade Xos Hub mobile charging system, marking its entry into defense.

/ Subscriber only
Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline
08/17/2026 · 4:49 PM

Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline

Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.

/ Subscriber only
EyePoint Trial Failure Seen as Positive for 4D Molecular’s 4D-150
Featured/ 08/17/2026 · 3:25 PM

B. Riley Keeps Buy on 4D Molecular After EyePoint’s Phase 3 Miss

4D Molecular gains support as B. Riley views EyePoint’s Phase 3 setback as favorable for its lead gene therapy candidate 4D-150.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe